140 results
Page 3 of 7
8-K
EX-10.1
rm1m4 z5ak2
13 Aug 21
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.1
m063r92619fowo s3v4
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
S-3ASR
EX-5.1
cr0shb8yc1bfe
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
fkmgrfoppm
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
EX-1.2
rniug46oux1sl
10 Aug 20
Automatic shelf registration
5:01pm
424B5
uks 0n04s7p2g
2 Jun 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-5.1
lvyzjxqqu xbkk
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
8-K
EX-1.1
wz7j2g wfoh6saez6
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
424B5
u5wc0ncwxqfi8a7i9 0s
1 Jun 20
Prospectus supplement for primary offering
6:06am
8-K
EX-10.1
op3hjs6 7uujm7r0h
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
8-K
d8q4 ll8ggsniuy
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
424B5
ywvv2detg 9s
22 Jan 20
Prospectus supplement for primary offering
5:31pm
8-K
EX-5.1
7e96d5kp
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm